| Parameter |
Descriptive Statistics |
EYECRYL-SERT (N=41) | ||
|---|---|---|---|---|
|
PO 01 Month |
PO 03 Month |
PO 06 Month |
||
| Uncorrected Distance VA (Log MAR) | N | 40 | 39 | 40 |
| - | Mean (SD) | 0.18 (0.11) | 0.15 (0.07) | 0.12 (0.08) |
| Median | 0.2 | 0.2 | 0.1 | |
| Min, Max | 0.0, 0.5 | 0.0, 0.2 | 0.0, 0.2 | |
| p-value | - | 0.0107 | <.0001 | |
| Uncorrected Distance VA Ref Range [n (%)] | 0-1 | 40 (97.56%) | 39 (95.12%) | 40 (97.56%) |
| - | >1 | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Uncorrected Intermediate VA (Log MAR) | N | 40 | 39 | 40 |
| - | Mean (SD) | 0.47 (0.08) | 0.47 (0.04) | 0.48 (0.04) |
| Median | 0.5 | 0.5 | 0.5 | |
| Min, Max | 0.3, 0.8 | 0.4, 0.5 | 0.4, 0.5 | |
| p-value | - | 0.7500 | 0.7500 | |
| Uncorrected Intermediate VA Ref Range [n (%)] | 0-1 | 40 (97.56%) | 39 (95.12%) | 40 (97.56%) |
| - | >1 | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Uncorrected Near VA (Log MAR) | N | 40 | 39 | 40 |
| - | Mean (SD) | 0.35 (0.11) | 0.38 (0.04) | 0.38 (0.04) |
| Median | 0.4 | 0.4 | 0.4 | |
| Min, Max | 0.0, 0.6 | 0.3, 0.4 | 0.3, 0.4 | |
| p-value | - | 0.2031 | 0.2500 | |
| Uncorrected Near VA Ref Range [n (%)] | 0-1 | 40 (97.56%) | 39 (95.12%) | 40 (97.56%) |
| - | >1 | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
|
Abbreviations: N=number of subjects in the specified treatment; n=number of subjects in the specified category; VA=visual acuity. Note 1: The given interval is inclusive of both values. Note 2: When screening visit data is not available we have considered 'PO 01 Month' visit data as baseline. Note 3: All parameters shows non-normality hence p-values obtained by using Wilcoxon signed-rank test. |
||||